A MULTICENTER, OBSERVATIONAL POST-MARKET CLINICAL FOLLOW-UP STUDY IN PATIENTS WITH RA, PSA, OR AXSPA ASSESSING THE PATIENT EXPERIENCE WITH THE CIMZIA AVA DEVICE OR OTHER TNF-BLOCKER AUTO-INJECTOR DEVICES.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
ACROMION GMBH
UCB BIOPHARMA SRL
Cita
A MULTICENTER, OBSERVATIONAL POST-MARKET CLINICAL FOLLOW-UP STUDY IN PATIENTS WITH RA, PSA, OR AXSPA ASSESSING THE PATIENT EXPERIENCE WITH THE CIMZIA AVA DEVICE OR OTHER TNF-BLOCKER AUTO-INJECTOR DEVICES. (DV0005). ACROMION GMBH; UCB BIOPHARMA SRL. 2020-2021. IP:JOSÉ ANDRÉS ROMÁN IVORRA.
Portal de investigación